Exhibit 107
Calculation of Filing Fee Table
SC TO-I
(Form Type)
Corcept Therapeutics Incorporated
(Exact Name of Registrant as Specified in its Charter)
Table 1 – Transaction Valuation
| Transaction Valuation |
Fee Rate |
Amount of Filing Fee | ||||
| Fees to Be Paid |
$165,000,000.00(1) | 0.00011020 | $18,183.00(2) | |||
| Fees Previously Paid |
— | — | — | |||
|
Total Transaction Valuation |
$165,000,000.00(1) | |||||
| Total Fees Due for Filing |
$18,183.00 | |||||
| Total Fees Previously Paid |
— | |||||
| Total Fee Offsets |
— | |||||
|
Net Fee Due |
$18,183.00 | |||||
| (1) | The transaction valuation is estimated only for purposes of calculating the filing fee. This amount is based on the purchase of 7,500,000 shares of common stock, par value $0.001 per share, at the maximum tender offer price of $22.00 per share. |
| (2) | The amount of the filing fee, calculated in accordance with Rule 0-11(b) of the Securities Exchange Act of 1934, as amended, equals $110.20 per $1,000,000 of the aggregate amount of the Transaction Valuation (or 0.01102% of the aggregate Transaction Valuation). The Transaction Valuation set forth above was calculated for the sole purpose of determining the filing fee and should not be used for any other purpose. |